Christopher A. Lipinski & Andrew G. Reaume. (2022). Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs. Frontiers Media S.A..
Chicago Style (17th ed.) CitationChristopher A. Lipinski and Andrew G. Reaume. Phenotypic Screening of Low Molecular Weight Compounds Is Rich Ground for Repurposed, On-target Drugs. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationChristopher A. Lipinski and Andrew G. Reaume. Phenotypic Screening of Low Molecular Weight Compounds Is Rich Ground for Repurposed, On-target Drugs. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.